Vanda Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ US9216591084

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Mihael Hristos Polymeropoulos. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Mihael Hristos Polymeropoulos telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:VNDA / Vanda Pharmaceuticals Inc. President and CEO, Director 2,335,731
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Mihael Hristos Polymeropoulos. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam VNDA / Vanda Pharmaceuticals Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di VNDA / Vanda Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2025-08-07 VNDA Polymeropoulos Mihael Hristos 10,000 4.1500 10,000 4.1500 41,500 15 4.7500 6,000 14.46
2025-05-21 VNDA Polymeropoulos Mihael Hristos 9,519 4.4000 9,519 4.4000 41,884
2025-05-21 VNDA Polymeropoulos Mihael Hristos 481 4.3900 481 4.3900 2,112
2025-05-16 VNDA Polymeropoulos Mihael Hristos 20,000 4.2236 20,000 4.2236 84,472
2025-03-06 VNDA Polymeropoulos Mihael Hristos 5,000 5.0200 5,000 5.0200 25,100
2025-03-06 VNDA Polymeropoulos Mihael Hristos 5,000 5.0100 5,000 5.0100 25,050
2025-03-05 VNDA Polymeropoulos Mihael Hristos 5,000 5.0100 5,000 5.0100 25,050
2025-03-05 VNDA Polymeropoulos Mihael Hristos 5,000 5.0300 5,000 5.0300 25,150
2025-03-03 VNDA Polymeropoulos Mihael Hristos 10,000 4.7050 10,000 4.7050 47,050
2025-02-28 VNDA Polymeropoulos Mihael Hristos 10,000 4.7600 10,000 4.7600 47,600
2025-02-27 VNDA Polymeropoulos Mihael Hristos 10,000 4.7600 10,000 4.7600 47,600
2025-02-26 VNDA Polymeropoulos Mihael Hristos 5,000 4.7500 5,000 4.7500 23,750
2025-02-26 VNDA Polymeropoulos Mihael Hristos 5,000 4.7800 5,000 4.7800 23,900
2025-02-25 VNDA Polymeropoulos Mihael Hristos 10,000 4.4640 10,000 4.4640 44,640
2011-08-23 VNDA Polymeropoulos Mihael Hristos 7,920 5.3476 7,920 5.3476 42,353
2011-08-22 VNDA Polymeropoulos Mihael Hristos 2,080 5.3423 2,080 5.3423 11,112

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

VNDA / Vanda Pharmaceuticals Inc. Insider Trades
Penjualan Orang Dalam VNDA / Vanda Pharmaceuticals Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di VNDA / Vanda Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2024-03-05 VNDA Polymeropoulos Mihael Hristos 24,288 4.1285 24,288 4.1285 100,273 13 3.7500 -9,193 -9.17
2024-03-04 VNDA Polymeropoulos Mihael Hristos 30,884 4.2438 30,884 4.2438 131,066
2023-03-03 VNDA Polymeropoulos Mihael Hristos 22,538 6.2506 22,538 6.2506 140,876
2023-03-02 VNDA Polymeropoulos Mihael Hristos 22,426 6.2302 22,426 6.2302 139,718
2022-12-06 VNDA Polymeropoulos Mihael Hristos 48,250 10.6131 48,250 10.6131 512,082
2022-12-05 VNDA Polymeropoulos Mihael Hristos 47,650 10.6233 47,650 10.6233 506,200
2022-03-02 VNDA Polymeropoulos Mihael Hristos 29,588 11.1513 29,588 11.1513 329,945
2022-03-01 VNDA Polymeropoulos Mihael Hristos 7,508 11.1900 7,508 11.1900 84,015
2021-12-01 VNDA Polymeropoulos Mihael Hristos 46,200 16.0032 46,200 16.0032 739,348
2021-11-30 VNDA Polymeropoulos Mihael Hristos 50,000 16.4855 50,000 16.4855 824,275
2021-03-08 VNDA Polymeropoulos Mihael Hristos 175,000 18.0003 175,000 18.0003 3,150,052
2021-03-02 VNDA Polymeropoulos Mihael Hristos 15,206 18.3416 15,206 18.3416 278,902
2021-03-01 VNDA Polymeropoulos Mihael Hristos 7,479 18.4520 7,479 18.4520 138,003
2020-12-15 VNDA Polymeropoulos Mihael Hristos 39,150 12.9973 39,150 12.9973 508,844
2020-12-14 VNDA Polymeropoulos Mihael Hristos 51,049 13.1894 51,049 13.1894 673,306
2020-12-11 VNDA Polymeropoulos Mihael Hristos 35,053 12.8765 35,053 12.8765 451,360
2020-03-03 VNDA Polymeropoulos Mihael Hristos 5,152 10.9752 5,152 10.9752 56,544
2020-03-02 VNDA Polymeropoulos Mihael Hristos 10,428 10.5688 10,428 10.5688 110,211
2020-01-02 VNDA Polymeropoulos Mihael Hristos 9,467 16.0022 9,467 16.0022 151,493
2019-12-12 VNDA Polymeropoulos Mihael Hristos 70,036 16.9820 70,036 16.9820 1,189,351
2019-12-11 VNDA Polymeropoulos Mihael Hristos 72,373 16.9176 72,373 16.9176 1,224,377
2019-05-21 VNDA Polymeropoulos Mihael Hristos 72,872 15.3413 72,872 15.3413 1,117,951
2019-05-20 VNDA Polymeropoulos Mihael Hristos 67,418 15.1159 67,418 15.1159 1,019,084
2019-05-17 VNDA Polymeropoulos Mihael Hristos 77,225 15.5609 77,225 15.5609 1,201,691
2019-03-04 VNDA Polymeropoulos Mihael Hristos 38,166 19.4100 38,166 19.4100 740,802
2019-03-01 VNDA Polymeropoulos Mihael Hristos 6,500 20.2190 6,500 20.2190 131,424
2019-01-03 VNDA Polymeropoulos Mihael Hristos 4,447 26.0410 4,447 26.0410 115,804
2019-01-02 VNDA Polymeropoulos Mihael Hristos 7,733 26.3220 7,733 26.3220 203,548
2019-01-02 VNDA Polymeropoulos Mihael Hristos 3,056 26.9340 3,056 26.9340 82,310
2018-03-01 VNDA Polymeropoulos Mihael Hristos 60,966 18.7154 60,966 18.7154 1,141,003
2018-01-02 VNDA Polymeropoulos Mihael Hristos 170,225 15.2958 170,225 15.2958 2,603,728
2018-01-02 VNDA Polymeropoulos Mihael Hristos 21,535 15.2960 21,535 15.2960 329,399
2017-01-03 VNDA Polymeropoulos Mihael Hristos 23,330 15.4840 23,330 15.4840 361,242
2016-01-04 VNDA Polymeropoulos Mihael Hristos 21,353 8.9600 21,353 8.9600 191,323
2015-09-10 VNDA Polymeropoulos Mihael Hristos 102,162 12.7298 102,162 12.7298 1,300,502
2015-09-09 VNDA Polymeropoulos Mihael Hristos 29,577 12.5092 29,577 12.5092 369,985
2015-05-22 VNDA Polymeropoulos Mihael Hristos 169,238 10.3644 169,238 10.3644 1,754,050
2015-05-21 VNDA Polymeropoulos Mihael Hristos 17,157 10.3332 17,157 10.3332 177,287
2015-03-10 VNDA Polymeropoulos Mihael Hristos 21,900 10.5300 21,900 10.5300 230,607
2013-11-19 VNDA Polymeropoulos Mihael Hristos 8,928 12.0726 8,928 12.0726 107,784
2012-02-16 VNDA Polymeropoulos Mihael Hristos 11,350 4.6920 11,350 4.6920 53,254

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

VNDA / Vanda Pharmaceuticals Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Mihael Hristos Polymeropoulos sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-08-08 2025-08-07 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 10,000 2,335,731 0.43 4.15 41,500 9,693,284
2025-05-21 2025-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 481 2,325,731 0.02 4.39 2,112 10,209,959
2025-05-21 2025-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 9,519 2,325,250 0.41 4.40 41,884 10,231,100
2025-05-19 2025-05-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 20,000 2,315,731 0.87 4.22 84,472 9,780,721
2025-03-06 2025-03-06 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 5,000 2,295,731 0.22 5.01 25,050 11,501,612
2025-03-06 2025-03-06 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 5,000 2,290,731 0.22 5.02 25,100 11,499,470
2025-03-05 2025-03-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 5,000 2,285,731 0.22 5.03 25,150 11,497,227
2025-03-05 2025-03-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 5,000 2,280,731 0.22 5.01 25,050 11,426,462
2025-03-04 2025-03-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 10,000 2,275,731 0.44 4.70 47,050 10,707,314
2025-03-04 2025-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
F - Taxes -95,999 2,265,731 -4.06 4.76 -456,955 10,784,880
2025-02-28 2025-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 10,000 2,361,730 0.43 4.76 47,600 11,241,835
2025-02-27 2025-02-27 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 10,000 2,351,730 0.43 4.76 47,600 11,194,235
2025-02-26 2025-02-26 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 5,000 2,341,730 0.21 4.78 23,900 11,193,469
2025-02-26 2025-02-26 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 5,000 2,336,730 0.21 4.75 23,750 11,099,468
2025-02-25 2025-02-25 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 10,000 2,331,730 0.43 4.46 44,640 10,408,843
2025-02-20 2025-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 450,000 2,321,730 24.04
2024-03-06 2024-03-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -24,288 1,871,730 -1.28 4.13 -100,273 7,727,437
2024-03-06 2024-03-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -30,884 1,896,018 -1.60 4.24 -131,066 8,046,321
2024-02-21 2024-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 450,000 1,926,902 30.47
2023-03-06 2023-03-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -22,538 1,476,902 -1.50 6.25 -140,876 9,231,524
2023-03-06 2023-03-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -22,426 1,499,440 -1.47 6.23 -139,718 9,341,811
2023-02-21 2023-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 115,000 1,521,866 8.17
2022-12-07 2022-12-06 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -48,250 1,406,866 -3.32 10.61 -512,082 14,931,210
2022-12-07 2022-12-06 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 75,365 1,455,116 5.46 3.12 235,139 4,539,962
2022-12-07 2022-12-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -47,650 1,379,751 -3.34 10.62 -506,200 14,657,509
2022-12-07 2022-12-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 74,635 1,427,401 5.52 3.12 232,861 4,453,491
2022-03-02 2022-03-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -29,588 1,352,766 -2.14 11.15 -329,945 15,085,099
2022-03-02 2022-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -7,508 1,382,354 -0.54 11.19 -84,015 15,468,541
2022-03-02 2022-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 275,000 275,000
2022-03-02 2022-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 115,000 1,389,862 9.02
2021-12-02 2021-12-01 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -71,676 0 -100.00
2021-12-02 2021-12-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -46,200 1,274,862 -3.50 16.00 -739,348 20,401,872
2021-12-02 2021-12-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 71,676 1,321,062 5.74 4.88 349,779 6,446,783
2021-12-02 2021-11-30 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -78,324 71,676 -52.22
2021-12-02 2021-11-30 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -50,000 1,249,386 -3.85 16.49 -824,275 20,596,753
2021-12-02 2021-11-30 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 78,324 1,299,386 6.41 4.88 382,221 6,341,004
2021-03-09 2021-03-08 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -175,000 1,221,062 -12.54 18.00 -3,150,052 21,979,482
2021-03-03 2021-03-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -15,206 1,396,062 -1.08 18.34 -278,902 25,606,011
2021-03-03 2021-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -7,479 1,411,268 -0.53 18.45 -138,003 26,040,717
2021-02-26 2021-02-24 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 275,000 275,000
2021-02-26 2021-02-24 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 115,000 1,418,747 8.82
2020-12-15 2020-12-15 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -46,663 0 -100.00
2020-12-15 2020-12-15 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -39,150 1,303,747 -2.92 13.00 -508,844 16,945,191
2020-12-15 2020-12-15 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 46,663 1,342,897 3.60 8.75 408,301 11,750,349
2020-12-15 2020-12-14 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -61,520 46,663 -56.87
2020-12-15 2020-12-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -51,049 1,296,234 -3.79 13.19 -673,306 17,096,549
2020-12-15 2020-12-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 61,520 1,347,283 4.78 8.75 538,300 11,788,726
2020-12-15 2020-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -41,817 108,183 -27.88
2020-12-15 2020-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -35,053 1,285,763 -2.65 12.88 -451,360 16,556,127
2020-12-15 2020-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 41,817 1,320,816 3.27 8.75 365,899 11,557,140
2020-03-04 2020-03-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -5,152 1,278,999 -0.40 10.98 -56,544 14,037,270
2020-03-04 2020-03-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -10,428 1,284,151 -0.81 10.57 -110,211 13,571,935
2020-02-28 2020-02-26 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 140,000 140,000
2020-02-28 2020-02-26 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 60,000 1,294,579 4.86
2020-01-06 2020-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -9,467 1,234,579 -0.76 16.00 -151,493 19,755,980
2019-12-13 2019-12-12 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -85,801 0 -100.00
2019-12-13 2019-12-12 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -70,036 1,244,046 -5.33 16.98 -1,189,351 21,126,389
2019-12-13 2019-12-12 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 85,801 1,314,082 6.99 10.65 913,781 13,994,973
2019-12-13 2019-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -89,199 85,801 -50.97
2019-12-13 2019-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -72,373 1,228,281 -5.56 16.92 -1,224,377 20,779,567
2019-12-13 2019-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 89,199 1,300,654 7.36 10.65 949,969 13,851,965
2019-05-21 2019-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -79,019 0 -100.00
2019-05-21 2019-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -72,872 1,211,455 -5.67 15.34 -1,117,951 18,585,295
2019-05-21 2019-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 79,019 1,284,327 6.56 12.55 991,688 16,118,304
2019-05-21 2019-05-20 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -73,608 79,019 -48.23
2019-05-21 2019-05-20 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -67,418 1,205,308 -5.30 15.12 -1,019,084 18,219,315
2019-05-21 2019-05-20 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 73,608 1,272,726 6.14 12.55 923,780 15,972,711
2019-05-21 2019-05-17 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -97,373 152,627 -38.95
2019-05-21 2019-05-17 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -77,225 1,199,118 -6.05 15.56 -1,201,691 18,659,355
2019-05-21 2019-05-17 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 97,373 1,276,343 8.26 12.55 1,222,031 16,018,105
2019-03-04 2019-03-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -38,166 1,178,970 -3.14 19.41 -740,802 22,883,808
2019-03-04 2019-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -6,500 1,217,136 -0.53 20.22 -131,424 24,609,273
2019-03-01 2019-02-27 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 140,000 140,000
2019-03-01 2019-02-27 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 60,000 1,223,636 5.16
2019-01-04 2019-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -4,447 1,163,636 -0.38 26.04 -115,804 30,302,245
2019-01-04 2019-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -3,056 1,168,083 -0.26 26.93 -82,310 31,461,148
2019-01-04 2019-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -7,733 1,171,139 -0.66 26.32 -203,548 30,826,721
2019-01-04 2018-12-24 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
G - Gift -4,000 1,178,872 -0.34
2018-03-02 2018-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -60,966 1,182,872 -4.90 18.72 -1,141,003 22,137,923
2018-03-02 2018-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 140,000 140,000
2018-03-02 2018-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 60,000 1,243,838 5.07
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -18,750 37,500 -33.33
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 12,500 -50.00
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 12,500 -50.00
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -250,000 0 -100.00
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -21,535 1,183,838 -1.79 15.30 -329,399 18,107,986
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 18,750 1,205,373 1.58
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 1,149,123 1.10
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 1,149,123 1.10
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -170,225 1,111,623 -13.28 15.30 -2,603,728 17,003,163
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 250,000 1,281,848 24.23 5.76 1,440,000 7,383,444
2018-01-04 2017-12-28 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
G - Gift -10,000 1,031,848 -0.96
2017-03-03 2017-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 275,000 275,000
2017-03-03 2017-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
A - Award 200,000 1,041,848 23.76
2017-02-06 2016-12-23 5 VNDA Vanda Pharmaceuticals Inc.
Common Stock
G - Gift -9,000 830,178 -1.07
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -18,750 56,250 -25.00
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 25,000 -33.33
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 25,000 -33.33
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -6,250 0 -100.00
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -23,330 850,848 -2.67 15.48 -361,242 13,174,530
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 18,750 874,178 2.19
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 855,428 1.48
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 855,428 1.48
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 6,250 830,428 0.76
2016-02-17 2016-02-12 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
A - Award 75,000 75,000
2016-02-17 2016-02-12 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 175,000 175,000
2016-02-12 2015-12-28 5 VNDA Vanda Pharmaceuticals Inc.
Common Stock
G - Gift -15,000 801,781 -1.84
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 37,500 -25.00
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 37,500 -25.00
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 25,000 -33.33
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -6,250 6,250 -50.00
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -21,353 839,178 -2.48 8.96 -191,323 7,519,035
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 860,531 1.47
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 860,531 1.47
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 848,031 1.50
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 6,250 835,531 0.75
2015-09-11 2015-09-10 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -147,626 0 -100.00
2015-09-11 2015-09-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -102,162 816,781 -11.12 12.73 -1,300,502 10,397,459
2015-09-11 2015-09-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 147,626 918,943 19.14 4.73 698,271 4,346,600
2015-09-11 2015-09-09 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -42,747 147,626 -22.45
2015-09-11 2015-09-09 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -29,577 771,317 -3.69 12.51 -369,985 9,648,559
2015-09-11 2015-09-09 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 42,747 800,894 5.64 4.73 202,193 3,788,229
2015-05-26 2015-05-22 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -359,815 0 -100.00
2015-05-26 2015-05-22 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -169,238 758,147 -18.25 10.36 -1,754,050 7,857,739
2015-05-26 2015-05-22 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 359,815 927,385 63.40 0.33 119,099 306,964
2015-05-26 2015-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -35,806 359,815 -9.05
2015-05-26 2015-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -17,157 567,570 -2.93 10.33 -177,287 5,864,814
2015-05-26 2015-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 35,806 584,727 6.52 0.33 11,852 193,545
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 37,500 -25.00
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 37,500 -25.00
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -6,250 12,500 -33.33
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 12,500 -50.00
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -21,900 548,921 -3.84 10.53 -230,607 5,780,138
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 570,821 2.24
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 570,821 2.24
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 570,821 2.24
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 6,250 558,321 1.13
2015-02-09 2015-02-05 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -48,154 0 -100.00
2015-02-09 2015-02-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
F - Taxes -24,947 527,071 -4.52 11.28 -281,402 5,945,361
2015-02-09 2015-02-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 48,154 552,018 9.56 0.03 1,594 18,272
2014-12-05 2014-12-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Units
A - Award 50,000 50,000
2014-12-05 2014-12-04 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 150,000 150,000
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Units
M - Exercise -6,250 18,750 -25.00
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Units
M - Exercise -12,500 25,000 -33.33
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Units
M - Exercise -12,500 25,000 -33.33
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -18,750 0 -100.00
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
F - Taxes -17,772 503,864 -3.41 13.46 -239,211 6,782,009
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 6,250 521,636 1.21
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 515,386 2.49
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 515,386 2.49
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 18,750 490,386 3.98
2013-12-04 2013-12-02 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
A - Award 50,000 50,000
2013-12-04 2013-12-02 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 150,000 150,000
2013-11-21 2013-11-19 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -8,928 471,636 -1.86 12.07 -107,784 5,693,873
2013-07-31 2013-07-29 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -25,000 25,000 -50.00
2013-07-31 2013-07-29 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 25,000 480,564 5.49
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 37,500 -25.00
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 37,500 -25.00
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -18,750 18,750 -50.00
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
F - Taxes -16,836 455,564 -3.56 3.95 -66,502 1,799,478
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 472,400 2.72
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 472,400 2.72
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 18,750 447,400 4.37
2012-12-11 2012-12-07 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
A - Award 50,000 50,000
2012-12-11 2012-12-07 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 150,000 150,000
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12,500 37,500 -25.00
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -18,750 37,500 -33.33
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -11,350 428,650 -2.58 4.69 -53,254 2,011,226
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12,500 440,000 2.92
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 18,750 427,500 4.59
2012-02-13 2011-08-23 4/A VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 7,920 408,750 1.98 5.35 42,353 2,185,832
2012-02-13 2011-08-22 4/A VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 2,080 400,830 0.52 5.34 11,112 2,141,354
2012-02-13 2011-02-18 5 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -18,750 56,250 -25.00
2012-02-13 2011-02-18 5 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 18,750 408,750 4.81
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)